We evaluated the relation between venous thrombosis and plasma fibrinogen l
evels, the HaeIII and BcI polymorphisms of the beta fibrinogen gene, and th
e MspI polymorphisms of the factor VII gene in a case-control study of Afri
can-Americans. The study included 91 venous thrombosis cases and 185 contro
l subjects obtained from a hospital in Atlanta, Georgia. High plasma fibrin
ogen was associated with increased risk of venous thrombosis, but the findi
ng was not statistically significant. There was little association between
the HaeIII polymorphisms and the BclI polymorphisms and the risk of venous
thrombosis. The prevalence of the M2/M2 genotype of the factor VII gene was
higher among cases than controls, but the difference was not statistically
significant. The prevalence of the HaeIII H2 allele and the BclI B2 allele
of the beta fibrinogen gene, both of which have been associated with sligh
tly higher levels of plasma fibrinogen in most studies, is considerably low
er among African-Americans in this study than it is among Whites in the Uni
ted States and among Northern Europeans. The study is limited by its small
size. However, despite this limitation, it supports the belief that increas
ed plasma fibrinogen levels are associated with increased venous thrombosis
risk. The study also indicated that the HaeIII and the BclI polymorphisms
of the beta fibrinogen gene and the MspI polymorphisms of the factor VII ge
ne are not strong determinants of venous thrombosis. (C) 2000 Elsevier Scie
nce Inc. All rights reserved.